Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.34 USD | -1.42% | -7.57% | +68.75% |
May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |